BioSpace News Archive

Researchers find the timing and length of use for corticosteroids has a particularly strong impact on the likelihood of severe, life-threatening adverse events for people with cancer.

Goldman Sachs leads investment to expand on-demand primary care service

Patent Application is specific to the United States.

The study will evaluate the safety and efficacy of in vitro expanded peripheral blood CD34+ stem cells output by the StemXpand® Automated Process and delivered via BioCardia’s Helix™ Biotherapeutic Delivery System for the treatment of patients soon after a heart attack.

As part of their lending process, HealthGrowth Capital will recommend community pharmacies complete a 360° Store Assessment through HRG.

The Fasano Longevity Conference, which will be held on November 5th in Washington, DC, will include a broad range of topics bearing on longevity markets.

Andersen will oversee continued global expansion of pharma exhibitions including the global CPhI series and Pharmapack Europe

0ForeverGreen™ Worldwide Corporation announces cutting-edge system modernizing and upgrading with new virtual back office platform.

G3 Pharmaceuticals, a development-stage biopharmaceutical company located in Burlington, MA, today announced the signing of an exclusive license and option agreement with Henry Ford Health System, based in Detroit, MI, for development and commercialization of galectin-3 inhibitors for treatment of diastolic heart failure, also known as heart failure with preserved ejection fraction or HFpEF.

Community health and nutrition programs will build on HCSC’s longstanding efforts to help members and communities be at their best